|
Invited Speakers:
|
|
Dr Hans-Peter Knopf, Head Protein Expression Technologies, Novartis Pharma
Hans Huber, Technology Agent – Biopharmaceutical Production, Boehringer Ingelheim GmbH
Dr Friedrich Nachtmann, Head Cooperations Biopharmaceuticals, Sandoz GmbH
Prof John Birch, Chief Scientific Officer, Lonza Biologics
Ache Stokelman, Senior Process Development Engineer, Technology Development Department, Amgen
Dr Alain Pralong, Head of PTBB-T, Pharmaceuticals Division, Biotech Manufacturing Basel, F. Hoffman-La Roche AGAnd many more
|
|